Summit State Bank welcomes Dr. Frank Chong and James Finley to its Board of Directors
SANTA ROSA, Calif., March 29, 2024 (GLOBE NEWSWIRE) — Summit State Bank (NASDAQ: SSBI) welcomes Dr. Frank Chong and James […]
Battalion Oil Corporation Announces Fourth Quarter 2023 Financial and Operating Results
HOUSTON, March 29, 2024 (GLOBE NEWSWIRE) — Battalion Oil Corporation (NYSE American: BATL, “Battalion” or the “Company”) today announced financial […]
Power REIT Receives Audit Opinion with Going Concern Explanation
Old Bethpage, New York, March 29, 2024 (GLOBE NEWSWIRE) — Power REIT (NYSE-AMEX: PW and PW.PRA) (“Power REIT” or the […]
TSX News -
Titan Medical Reports Fiscal Year 2023 Results
TORONTO, Ontario, March 29, 2024 (GLOBE NEWSWIRE) — Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), today […]
Weekly Report (March 22-28, 2024) on the First Tranch of Stellantis 2024 Share Buyback Program
Weekly Report (March 22-28, 2024) on the First Tranch of Stellantis 2024 Share Buyback Program AMSTERDAM, March 29, 2024 – Stellantis […]
UPDATE – Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines
Study to determine the efficacy of Telomir-1 on mitigating the clinical signs of osteoarthritis and other age-related diseases This study […]
Information on the total number of voting rights and shares
REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), March 29, 2024, 9:30 pm CET […]
Northrim BanCorp, Inc. Promotes Huston to President and CEO; Schierhorn Remains Chairman
ANCHORAGE, Alaska, March 29, 2024 (GLOBE NEWSWIRE) — The Board of Directors of Northrim BanCorp Inc., the parent company of […]
Strong Global Entertainment Reports Fourth Quarter and Full Year 2023 Operating Results
Charlotte, N.C., March 29, 2024 (GLOBE NEWSWIRE) — Strong Global Entertainment, Inc. (NYSE American: SGE) (the “Company” or “Strong Global […]
AEON Biopharma Announces Redemption of Public Warrants
IRVINE, Calif., March 29, 2024 (GLOBE NEWSWIRE) — AEON Biopharma, Inc. (NYSE: AEON; AEON.WS) (“AEON” or “the Company”), a clinical-stage […]
